Add like
Add dislike
Add to saved papers

En-bloc resection of thoracic tumors invading the spine: a single-center experience.

BACKGROUND: Vertebral involvement by a thoracic tumor has long been considered as a limit to surgical treatment, and despite advances, such an invasive surgery remains controversial. The aim of this study was to characterize a single-center cohort, and to evaluate the outcome, focusing on survival and complications.

METHODS: We retrospectively reviewed the data of all patients operated on for tumors involving the thoracic spine in an 8-year period. En-bloc resection was generally performed by a double team involving thoracic and orthopedic surgeons. Distant follow-up was recorded for oncological and functional analysis.

RESULTS: 31 patients were operated on. An induction-therapy was administered in 20 cases. Spinal resection (mostly including ≥2 vertebral levels) was combined with lobectomy in almost half cases; osteosynthesis was required in 22 patients. We observed no in-hospital death, and a major complications rate of 32.3% including 5 cases of early neurological complications. There were 61.3% primary lung carcinomas, 12.9% extra-pulmonary primaries, 9.7% metastases and 16.1% benign tumors. Mean follow-up was 32.1 months. Five-year overall-survival-rate was 81.3% in the whole cohort and 75.0% in patients with a malignant tumor. Occurrence of an early postoperative major complication was the only factor significantly associated with shorter overall-survival (p=0.03). Five-year disease-free-survival rate was 37.0% in malignancies. Delayed complications occurred in 35.5% of patients including persistent neurologic deficit (12.9%), instrumentation migration (19.4%), and local infection (12.9%).

CONCLUSIONS: En-bloc resection of spinal thoracic tumors offers long-term survival and few recurrences in highly selected patients but is associated with significant delayed mechanical and/or infectious complications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app